CA2329103C

Dialyzers for blood treatment and processes for production thereof

Abstract

The present invention relates to a dialyzer for blood treatment having incorporated therein a semipermeable membrane which comprises a hydrophobic polymer and a hydrophilic polymer, the water permeating performance of the semipermeable membrane after drying being 1/2 or higher relative to that before drying and the dialyzer satisfying any of the following requirements: (A) the vitamin B12 clearance is not smaller than 135 ml/min per 1.6 m2; and (B) the amount of the hydrophilic polymer that is eluted from the semipermeable membrane is not higher than 10 ppm. The invention also relates to a process for producing a dialyzer having incorporated therein a semipermeable membrane which comprises a hydrophobic polymer and a hydrophilic polymer, the process comprising: drying the semipermeable membrane; and saturating the dried semipermeable membrane with water ratio of not smaller than 100% based on the dry weight of the semipermeable membrane, providing an inert gas atmosphere to the inside of the dialyzer, and then irradiating the semipermeable membrane with gamma-ray in the inert gas atmosphere. The invention further relates to a process for producing a hollow fiber membrane for use in blood treatment through dry/wet spinning from a stock solution comprising 15 to 18% by weight of a hydrophobic polymer and 4 to 8% by weight of a hydrophilic polymer, the dry zone being filled with dry mist. The dialyzer includes a dry-type semipermeable membrane having less change in performance before and after drying and high water permeability and dialyzing performance, is light-weight, easy to handle, and exhibits a reduced elution of a hydrophilic polymer.

CA2329103C, drawing sheet 1
Sheet 1 of 2

Term

Term ended

Expired 20 December 2020, 5.8 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

17 claims: 3 independent, 14 dependent

  1. 1
    CA 02329103 2008-03-11 76199-168 CLAIMS :1. A dialyzer for blood treatment having incorporated therein a semipermeable membrane which comprises a hydrophobic polymer and a hydrophilic polymer, and which has a water permeating performance after drying at 100°C for 24 hours of 1/2 or higher relative to that before drying, wherein an amount of the hydrophilic polymer that is eluted from the semipermeable membrane of not higher than 10 ppm.
  2. 12
    A process for producing a dialyzer having incorporated therein a semipermeable membrane which comprises a hydrophobic polymer and a hydrophilic polymer, the process comprising:drying the semipermeable membrane;and saturating the dried semipermeable membrane with water at a water ratio of not smaller than 100% based on the dry weight of the semipermeable membrane, providing an inert -30CA 02329103 2007-07-19 76199-168 gas atmosphere to the inside of the dialyzer, and then irradiating the semipermeable membrane with gamma-ray in the inert gas atmosphere.
  3. 17
    A process for producing the dialyzer for blood treatment as defined in claim 1, 2 or 3, which comprises:(A) providing a spinning solution containing the hydrophobic polymer, the hydrophilic polymer, an additive which is a poor solvent for the hydrophobic polymer but is miscible with the hydrophilic polymer, and an amphiprotic solvent which can dissolve the hydrophobic polymer, the hydrophilic polymer and the additive;(B) extruding the spinning solution along with a core solution from a spinneret through an annular double slit to form a hollow fiber membrane by a dry/wet spinning process in which the spun hollow fiber membrane is passed first through a dry zone atomosphere containing dry mist that is a mist-like material comprising water particles of 10pm or smaller and then through a coagulation bath to -31CA 02329103 2007-07-19 76199-168 remove phases of the hydrophilic polymer, thereby generating pores on an outer surface of the hollow fiber membrane;(C) washing the resulting hollow fiber membrane with water;5 (D) drying the washed hollow fiber membrane without a moisture retaining agent, crimping the dried hollow fiber membrane and then cutting the crimped hollow fiber membrane to an appropriate length;(E) fabricating a dialyzer module made of a bundle 10 of the cut hollow fiber semipermeable membranes by sealing both ends of the bundle with a potting material so that the module has open faces at the both ends;(F) filling a blood side of the module with warm water and then replacing the water by an inert gas, whereby 15 the hollow fiber semipermeable membranes are saturated with water at a water ratio of 100 to 1000% based on a dry weight of the semipermeable membranes;(G) replacing atmospheric air on a dialyzate side of the module by the inert gas;and 20 (H) irradiating the semipermeable membranes with gamma-ray. SMART & BIGGAR OTTAWA, CANADA PATENT AGENTS